Risk of malignancy associated with cyclosporin use in psoriasis.
Paul
C
C
Hornig
F
F
D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy*; D012307:Risk Factors
D003879:Dermatologic Agents; D016572:Cyclosporine